Post-Finasteride Syndrome And The Impact Of 5-Alpha Reductase Inhibitors On Neuroendocrine And Metabolic Axes
May 2026
in “
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
”
Post-Finasteride Syndrome 5-alpha reductase inhibitors 5-ARIs finasteride neuroendocrine impacts metabolic impacts refractory sexual dysfunction mood disorders allopregnanolone GABAergic dysregulation excitotoxicity dihydrotestosterone insulin resistance non-alcoholic fatty liver disease Type 2 Diabetes Mellitus gut microbiota SRD5A2 gene DNA methylation androgen receptor personalized medicine PFS DHT NAFLD T2DM
Studysummary This study reviewed recent scientific evidence on the neuroendocrine and metabolic impacts of chronic use of 5-alpha reductase inhibitors, detailing its association with sexual dysfunction, mood disorders, insulin resistance, and other metabolic disorders, suggesting persistent biopsycho-social risks beyond transient side effects in users.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on recima21.com.br →